Aspira Pathlab Diagnostics Ltd vs Sangani Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd changed from 43.3 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Sangani Hospitals Ltd changed from 21.7 on March 2024 to 17.9 on March 2026 . This represents a CAGR of -3.78% over 5 years The Market Cap of Aspira Pathlab & Diagnostics Ltd changed from ₹ 31.91 crore on March 2024 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Sangani Hospitals Ltd changed from ₹ 58.55 crore on March 2024 to ₹ 53.59 crore on March 2026 . This represents a CAGR of -1.75% over 5 years The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 5.36 crore as compare to the Mar '25 revenue of ₹ 5.91 crore. This represent the decline of -9.31% The revenue of Sangani Hospitals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 0.79 crore as compare to the Mar '25 ebitda of ₹ 1.05 crore. This represent the decline of -24.76% The ebitda of Sangani Hospitals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0.42 crore over 5 quarters. This represents a CAGR of 448.81% The net profit of Sangani Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sangani Hospitals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About Sangani Hospitals Ltd

Sangani Hospitals Limited was incorporated as a Public Limited Company in Keshod, Gujarat on November 11, 2021, through Certificate of Incorporation dated November 12, 2021 and Certificate of Commencement of Business dated December 14, 2021 issued by the Registrar of Companies, Ahmedabad.
Sangani Group is a healthcare organization founded by the Promoter, Dr. Ajaykumar Sangani. Sangani Hospital is 36 beds multi-speciality hospital with primary, secondary and tertiary care facilities.
Presently, the Company is into the business of Hospitals, pathological laboratory and Pharmacy stores at Keshod and Veraval location in Gujarat.
The Company is a multi-speciality healthcare provider operating in Keshod and Veraval region of Gujarat with a combined bed capacity of 170 beds.
Their services include super speciality services, speciality services and other support services.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and Sangani Hospitals Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or Sangani Hospitals Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of Sangani Hospitals Ltd is 82 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and Sangani Hospitals Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and Sangani Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and Sangani Hospitals Ltd?

As of October 24, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, Sangani Hospitals Ltd stock price is INR ₹59.7.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and Sangani Hospitals Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and Sangani Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.